Europe has reached a pivotal point in the digital transformation of its health sector. Rapid advances in artificial intelligence – spanning diagnostics, personalised medicine, hospital optimisation and biomanufacturing – are reshaping expectations for the future of care. The rapid adoption of AI also raises complex questions around ethics, data governance, regulation and the readiness of health systems and professionals to integrate new technologies. The current AI Strategy emphasises the responsible integration of these technologies, prioritising ethical considerations and data protection to ensure public trust. At the same time, major legislative milestones such as the AI Act, the European Health Data Space (EHDS) Regulation and the European Biotech and Biomanufacturing Act are redefining the rules of the game, signalling the EU’s determination to lead globally in responsible health innovation.
Yet this progress is accompanied by significant challenges. The European Commission’s study on AI deployment in healthcare underscores continued fragmentation in data, uneven system readiness and uncertainty around how to operationalise new regulatory obligations. Strategy&’s latest analyses show AI’s market impact could more than double by 2030, but many organisations still struggle to extract tangible value, echoing findings from PwC’s CEO Survey. This tension captures Europe’s ‘good, bad and ugly’: extraordinary potential, mounting pressures, and the urgent need for coherent, trusted implementation.
Join us for a forward-looking stocktaking session on where Europe stands today in its journey towards AI‑enabled healthcare.
Drawing on insights from EU policy developments, industry research and real‑world deployment experiences, this session will explore what it will take to unlock AI’s full benefits while safeguarding patient trust, ethical standards and system resilience. As Europe enters a decisive period for digital health, understanding these dynamics is essential for shaping the path ahead.
This discussion will set the stage for What’s Next | Healthcare Series 2026.
Please note that this event is in-person only, with the exception of CEPS members who may request a link to follow virtually by emailing [email protected]
This event is organised in collaboration with PwC.
15:45-16:00 Registration
16:00-16:15 Welcome and Intro
Andrea Renda, Director of Research, CEPS
Philippe Pierre, Partner, PwC EU Services
16:15-16:30 Keynote 1
Topic: Overview of the current AI and health landscape at the Global level: the impact of AI on healthcare delivery, main challenges, impact of regulation, and market opportunities
Anthony Bruce, PwC Global Health Industries Leader
16:30-16:45 Keynote 2
Topic: The EU Apply AI strategy and the broader vision of the European Commission for AI and health
Lucilla Sioli, Director of the European AI Office, European Commission
16:45-17:30 Panel Discussion: AI in Health – Opportunities and Challenges
Moderator: Andrea Renda, Director of Research, CEPS
Speakers:
Alexander Olbrechts, Director of Digital Health & Medtech Value at MedTech Europe MedTech
Florence Baron-Papillon, Head of Strategic Projects, Corporate Public Affairs, Sanofi
Friederike Schuur, Head of EU and Global AI Governance, Ada Lovelace Institute
Lucilla Sioli, Director of the European AI Office, European Commission
17.30-18.15 Panel Discussion: Innovation Showcase
Moderator: Giovanna Galasso, Partner, PwC
Speakers:
Saverio D´Amico, Lead Data Scientist at Humanitas AI Center CEO and co-founder of Train
Sasa Kivisaari, Senior Lead, SITRA
Petra Ritter, Director for International Affairs, Charité Universitätsmedizin Berlin; Director, Brain Simulation Section, Berlin Institute of Health at the Charité Universitätsmedizin Berlin; Lead of the European Testing and Experimentation Facility for Health AI and Robotics (TEF-Health)
José María Veganzones Alonso-Cortés, Directorate-General for Digital Health within the Regional Ministry of Digitalization of Madrid
18:15-18:30 Summary & Closing
18:30 onwards Aperitif & Networking
